Publications by authors named "Okun M"

Background: Hidradenitis suppurativa (HS) affects different patient populations that require unique considerations in their management. However, no HS guidelines for these populations exist.

Objective: To provide evidence-based consensus recommendations for patients with HS in 7 special patient populations: (i) pregnancy, (ii) breastfeeding, (iii) pediatrics, (iv) malignancy, (v) tuberculosis infection, (vi) hepatitis B or C infection, and (vii) HIV disease.

View Article and Find Full Text PDF

Gilles de la Tourette Syndrome (GTS) is a chronic tic disorder, characterized by unwanted motor actions and vocalizations. While brain stimulation techniques show promise in reducing tic severity, optimal target networks are not well-defined. Here, we leverage datasets from two independent deep brain stimulation (DBS) cohorts and a cohort of tic-inducing lesions to infer critical networks for treatment and occurrence of tics by mapping stimulation sites and lesions to a functional connectome derived from 1,000 healthy participants.

View Article and Find Full Text PDF

Objective: Pregnancy is often typified with a decrease in sleep quality, which for many women, progressively worsens across gestation and into the postpartum. A mechanism linking poor sleep with certain adverse pregnancy outcomes is dysregulation of the HPA axis resulting in atypically elevated cortisol production. While total cortisol output normally increases across pregnancy, the cortisol awakening response (CAR), a response to waking up, is influenced by factors such as stress and mood.

View Article and Find Full Text PDF
Article Synopsis
  • The review discusses various innovative neuromodulatory methods being researched to manage motor symptoms in Parkinson's disease (PD).
  • Technologies mentioned include temporal interference, gene therapy, optogenetics, and advanced drug delivery systems like nanoparticles.
  • The findings suggest that these new approaches could lead to effective treatments for alleviating motor symptoms in PD patients.
View Article and Find Full Text PDF

Clinical Vignette: A 23-year-old woman with pantothenate kinase-associated neurodegeneration (PKAN) presented with medication-refractory generalized dystonia and an associated gait impairment.

Clinical Dilemma: Bilateral globus pallidus internus (GPi) deep brain stimulation (DBS) can be an effective treatment for dystonia. However, outcomes for PKAN DBS have been variable and there are no standardized criteria for patient selection.

View Article and Find Full Text PDF
Article Synopsis
  • Deep brain stimulation of the subthalamic nucleus (STN-DBS) offers motor benefits for Parkinson's disease patients, but its effectiveness on postural and gait issues remains uncertain.
  • Physical therapy (PT) has shown effectiveness in improving mobility and stability in non-surgically treated Parkinson's patients, but its role after STN-DBS is less explored.
  • A study involving 21 experts highlighted that while PT could enhance motor function and quality of life post-STN-DBS, there’s a preference for conventional therapies over massage or manual techniques.
View Article and Find Full Text PDF
Article Synopsis
  • Deep brain stimulation (DBS) of the subthalamic nucleus and globus pallidus internus is FDA-approved for treating dystonia, showing positive effects on symptoms.
  • However, patient outcomes post-surgery can differ widely, prompting the search for new targets in neuromodulation.
  • Recent research has identified promising alternative DBS targets and examined non-invasive methods to better understand the disease's underlying mechanisms.
View Article and Find Full Text PDF
Article Synopsis
  • The evolution of Deep Brain Stimulation (DBS) is shifting from conventional methods to adaptive techniques (aDBS), which are expected to become standard practice in the next decade, similar to past advancements in cardiac pacing.
  • Research involving 21 experts highlighted the challenges and potential of aDBS, showing consensus on its safety and effectiveness compared to conventional DBS, particularly for Parkinson's Disease patients with motor fluctuations and dyskinesias.
  • Further studies are necessary to refine the algorithms used in aDBS, ensuring its widespread and effective use in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on the risk of developing Parkinson's disease (PD) compared to dipeptidyl peptidase 4 inhibitors (DPP4i) in older adults with type 2 diabetes.
  • - Analysis of Medicare data from 2016 to 2020 revealed that GLP-1RA users had a lower incidence of PD (2.85 vs. 3.92 per 1000 person-years) and a 23% reduced risk of PD compared to DPP4i users.
  • - The findings suggest that GLP-1RAs may have a protective effect against PD in
View Article and Find Full Text PDF

Accurate tracking of the same neurons across multiple days is crucial for studying changes in neuronal activity during learning and adaptation. Advances in high-density extracellular electrophysiology recording probes, such as Neuropixels, provide a promising avenue to accomplish this goal. Identifying the same neurons in multiple recordings is, however, complicated by non-rigid movement of the tissue relative to the recording sites (drift) and loss of signal from some neurons.

View Article and Find Full Text PDF

Parkinson's disease (PD) is a serious neurodegenerative disorder marked by significant clinical and progression heterogeneity. This study aimed at addressing heterogeneity of PD through integrative analysis of various data modalities. We analyzed clinical progression data (≥5 years) of individuals with de novo PD using machine learning and deep learning, to characterize individuals' phenotypic progression trajectories for PD subtyping.

View Article and Find Full Text PDF

Clinical Vignette: A 63-year-old man with severe essential tremor underwent staged bilateral ventralis intermedius (Vim) deep brain stimulation (DBS). Left Vim DBS resulted in improved right upper extremity tremor control. Months later, the addition of right Vim DBS to the other brain hemisphere was associated with acute worsening of the right upper extremity tremor.

View Article and Find Full Text PDF

The term "catatonia" was introduced by German psychiatrist Karl Kahlbaum in 1874. Although historically tied to schizophrenia, catatonia exhibits a diverse range of phenotypes and has been observed in various medical and neuropsychiatric conditions. Its intrinsic movement characteristics and association with hypokinetic and hyperkinetic phenomenologies place catatonia within the purview of movement disorders.

View Article and Find Full Text PDF

Background: Responsive deep brain stimulation (rDBS) uses physiological signals to deliver stimulation when needed. rDBS is hypothesized to reduce stimulation-induced speech effects associated with continuous DBS (cDBS) in patients with essential tremor (ET).

Objective: To determine if rDBS reduces cDBS speech-related side effects while maintaining tremor suppression.

View Article and Find Full Text PDF
Article Synopsis
  • A study explored circadian rhythms in the globus pallidus internus (GPi) of Parkinson's disease patients, focusing on a cohort of 93 subjects with 130 recordings taken in their home environments.
  • Results revealed that 82.4% of subjects showed changes in GPi activity between day and night, with some experiencing reduced activity at night and others an increase.
  • Higher frequency activity (>20 Hz) in GPi was more likely to decrease at night, especially in patients on extended-release levodopa, indicating that fluctuating GPi activity could impact future neurostimulation treatments.
View Article and Find Full Text PDF

Objective: Cognitive changes are heterogeneous in Parkinson's disease (PD). This study compared whether anticholinergic burden drives differences in cognitive domain performance and empirically-derived PD-cognitive phenotypes.

Method: A retrospective chart review contained participants (n = 493) who had idiopathic PD without dementia.

View Article and Find Full Text PDF

Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder, with genetic factors accounting for about 15% of cases. There is a significant challenge in tracking disease progression and treatment response, crucial for developing new therapies. Traditional methods like imaging, clinical monitoring, and biomarker analysis have not conclusively tracked disease progression or treatment response in PD.

View Article and Find Full Text PDF

Objective: To determine if the co-occurrence of apathy and impulse control disorders (ICDs) in Parkinson disease is dependent on instrument selection and assess the concurrent validity of three motivation measures by examining interrelationships between them.

Method: Ninety-seven cognitively normal individuals with idiopathic Parkinson disease (PD) completed the Questionnaire for Impulsive-Compulsive Disorders in Parkinson Disease-Rating Scale (QUIP-RS) and three apathy measures: the Apathy Scale, Lille Apathy Rating Scale, and Item 4 of the Movement Disorder Society-Unified Parkinson Disease Rating Scale.

Results: Fifty (51.

View Article and Find Full Text PDF